About the job
Join Axsome Therapeutics, a pioneering biopharmaceutical company at the forefront of developing innovative treatments for central nervous system (CNS) disorders. We are dedicated to bridging critical gaps in patient care through scientific advancements and unique product offerings focused on novel mechanisms of action. Our renowned neuroscience portfolio includes FDA-approved therapies for major depressive disorder, narcolepsy-related excessive daytime sleepiness, obstructive sleep apnea, migraines, and several late-stage development initiatives targeting a wide spectrum of serious neurological and psychiatric disorders affecting over 150 million individuals in the United States. Together, we aim to overcome significant challenges in brain health, empowering both patients and their families to thrive.
